InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by 김영선, Directeur. Officer active across 2 companies, notably 동국생명과학. Cumulatively, 2 reports have been logged. Activity tracked since 8 April 2026. The latest transaction was filed on 8 April 2026 (Purchase). Regulator: DART (FSS). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Kim Young-sun is an Executive Director at Dongguk Life Science, a company active in the life sciences field. In this role, he oversees operations and contributes to product development strategy. Kim Young-sun is recognized for his expertise in the sector and for his ability to lead teams toward innovation. His commitment to quality and efficiency is essential for Dongguk Life Science's success.